GGrantIndex
← Leaderboards

Jason Gall

National Institute Of Allergy And Infectious Diseases

$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

By mechanism

Top collaborators

No co-investigators on record.

Most similar at National Institute Of Allergy And Infectious Diseases

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trials

Research focus

Clinical TrialsProgramsVaccinesClinical MaterialManufacturing ProcessVaccine ProductionLaboratoriesProductionPlantsNational Institute Of Allergy And Infectious DiseasePlacebosPhase I/Ii Clinical TrialClinicManufactureSafetyMonoclonal AntibodiesImmunityEvaluationHuman VolunteersInfluenza Virus VaccineDedicationsNanoparticleHiv VaccineAntibodies

Grant awards (36)

Operation of a Vaccine Pilot Plant$48,186,961
ZIB · FY2025 · AI · contact PI
Development and Production of Broadly Neutralizing HIV Antibodies$10,120,321
ZIB · FY2025 · AI · contact PI
Development and Production of HIV Vaccines and Adjuvants$10,098,321
ZIB · FY2025 · AI · contact PI
Development/production of universal influenza vaccines$4,931,770
ZIB · FY2025 · AI · contact PI
Biomedical Product Assessment$3,587,248
ZIB · FY2025 · AI · contact PI
Development and Production of Anti-Malarial Biologicals$179,362
ZIB · FY2025 · AI · contact PI
Development and Production of Investigational Products for Prevention of Mumps$179,362
ZIB · FY2025 · AI · contact PI
Establishment and operation of a Vaccine Pilot Plant$66,352,968
ZIB · FY2024 · AI · contact PI
Production of a Broadly Neutralizing HIV Antibodies$12,979,030
ZIB · FY2024 · AI · contact PI
Development and Production of HIV Vaccines and Adjuvants$10,557,332
ZIB · FY2024 · AI · contact PI
Development/production of universal influenza vaccines$8,780,594
ZIB · FY2024 · AI · contact PI
Development and Production of SARS-CoV2 Biologicals and Vaccines$629,324
ZIB · FY2024 · AI · contact PI
Development and Production of Anti-Malarial Biologicals$106,967
ZIB · FY2024 · AI · contact PI
Establishment and operation of a Vaccine Pilot Plant$66,062,291
ZIB · FY2023 · AI · contact PI
Development/production of universal influenza vaccines$25,850,000
ZIB · FY2023 · AI · contact PI
Production of a Broadly Neutralizing HIV Antibodies$13,723,802
ZIB · FY2023 · AI · contact PI
Development and Production of HIV Vaccines and Adjuvants$10,557,332
ZIB · FY2023 · AI · contact PI
Development and Production of SARS-CoV2 Biologicals and Vaccines$5,062,451
ZIB · FY2023 · AI · contact PI
Development and Production of Anti-Malarial Biologicals$112,196
ZIB · FY2023 · AI · contact PI
Establishment and operation of a Vaccine Pilot Plant$48,286,230
ZIB · FY2022 · AI · contact PI
Production of a Broadly Neutralizing HIV Antibodies$12,797,698
ZIB · FY2022 · AI · contact PI
Development and Production of HIV Vaccines and Adjuvants$9,487,666
ZIB · FY2022 · AI · contact PI
Development and Production of SARS-CoV2 Biologicals and Vaccines$4,391,926
ZIB · FY2022 · AI · contact PI
Development/production of universal influenza vaccines$2,001,000
ZIB · FY2022 · AI · contact PI
Development and Production of Anti-Malarial Biologicals$106,967
ZIB · FY2022 · AI · contact PI
Establishment and operation of a Vaccine Pilot Plant$44,917,715
ZIB · FY2021 · AI · contact PI
Production of a Broadly Neutralizing HIV Antibodies$12,600,129
ZIB · FY2021 · AI · contact PI
Development and Production of HIV Vaccines and Adjuvants$9,825,620
ZIB · FY2021 · AI · contact PI
Development and Production of SARS-CoV2 Biologicals and Vaccines$5,963,191
ZIB · FY2021 · AI · contact PI
Development/production of universal influenza vaccines$1,652,145
ZIB · FY2021 · AI · contact PI
Development and Production of Anti-Malarial Biologicals$819,667
ZIB · FY2021 · AI · contact PI
Establishment and operation of a Vaccine Pilot Plant$41,462,163
ZIB · FY2020 · AI · contact PI
Development/production of universal influenza vaccines$14,987,979
ZIB · FY2020 · AI · contact PI
Production of a Broadly Neutralizing HIV Antibodies$10,505,669
ZIB · FY2020 · AI · contact PI
Development and Production of HIV Vaccines and Adjuvants$6,197,003
ZIB · FY2020 · AI · contact PI
Development and Production of Anti-Malarial Biologicals$1,077,167
ZIB · FY2020 · AI · contact PI